{"context":{"query":">>mondo>>gwas","source_dataset":"mondo","target_dataset":"gwas"},"stats":{"queried":1,"total":79,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"MONDO:0008170","source":"MONDO:0008170|ovarian cancer","targets":["GCST90308764_1|Cancer|TRIM46|1|4.000000e-08","GCST90308764_10|Cancer|TESHL|2|2.000000e-10","GCST90308764_11|Cancer|PELO-AS1|5|1.000000e-08","GCST90308764_12|Cancer|CCDC170 - ESR1|6|3.000000e-09","GCST90308764_13|Cancer|HLA-DQB1|6|2.000000e-15","GCST90308764_14|Cancer|Y_RNA - AZGP1|7|3.000000e-09","GCST90308764_15|Cancer|PCAT1, CASC8, POU5F1B|8|9.000000e-29","GCST90308764_16|Cancer|PSCA - LY6K|8|3.000000e-12","GCST90308764_17|Cancer|CHCHD4P2 - RPL36P14|9|6.000000e-09","GCST90308764_18|Cancer|CDKN2B-AS1|9|6.000000e-11","GCST90308764_19|Cancer|STN1 - SLK|10|8.000000e-10","GCST90308764_2|Cancer|KCNQ1|11|5.000000e-09","GCST90308764_20|Cancer|FGFR2|10|1.000000e-21","GCST90308764_21|Cancer|RPL23AP61|10|2.000000e-10","GCST90308764_22|Cancer|KIF20B - MTND5P42|10|3.000000e-08","GCST90308764_23|Cancer|POU2AF3, COLCA1|11|2.000000e-09","GCST90308764_3|Cancer|LINC01488|11|8.000000e-14","GCST90308764_4|Cancer|RCCD1|15|1.000000e-08","GCST90308764_5|Cancer|TOX3|16|7.000000e-17","GCST90308764_6|Cancer|HNF1B|17|3.000000e-21","GCST90308764_7|Cancer|CASC17|17|8.000000e-10","GCST90308764_8|Cancer|SMAD7|18|2.000000e-08","GCST90308764_9|Cancer|LINC01101 - Y_RNA|2|9.000000e-09","GCST90651054_1|Cancer|LINC01661 - PRMT6|1|2.000000e-08","GCST90651054_10|Cancer|MRTFA|22|3.000000e-08","GCST90651054_11|Cancer|C5orf67 - MAP3K1|5|7.000000e-09","GCST90651054_12|Cancer|LINC-PINT|7|3.000000e-09","GCST90651054_13|Cancer|PCAT1, CASC8, POU5F1B|8|6.000000e-22","GCST90651054_14|Cancer|CHCHD4P2 - RPL36P14|9|2.000000e-09","GCST90651054_2|Cancer|STN1|10|1.000000e-10","GCST90651054_3|Cancer|FGFR2|10|1.000000e-25","GCST90651054_4|Cancer|RPL23AP61|10|7.000000e-10","GCST90651054_5|Cancer|LINC01488 - PNCRNA-D|11|1.000000e-15","GCST90651054_6|Cancer|TOX3|16|2.000000e-17","GCST90651054_7|Cancer|HNF1B|17|1.000000e-14","GCST90651054_8|Cancer|TESHL|2|6.000000e-10","GCST90651054_9|Cancer|LINC03086 - TGM3|20|4.000000e-08","GCST90651069_1|Cancer|IGF2BP2|3|2.000000e-08","GCST90651069_2|Cancer|TTC33|5|2.000000e-08","GCST90651069_3|Cancer|PELO-AS1|5|2.000000e-08","GCST90651069_4|Cancer|HLA-DQB1|6|2.000000e-13","GCST90651069_5|Cancer|PCAT1, PRNCR1, CASC19|8|2.000000e-15","GCST90651069_6|Cancer|PSCA, JRK|8|3.000000e-13","GCST90651069_7|Cancer|GBA1LP, GBA1LP|1|1.000000e-10","GCST90651069_8|Cancer|HNF1B|17|2.000000e-08","GCST90651512_1|Malignant neoplasm of ovary (PheCode 184.11)|ANAPC4|4|2.000000e-08","GCST90652081_1|Malignant neoplasm of ovary and other uterine adnexa (PheCode 184.1)|CWC22 - SCHLAP1|2|3.000000e-07","GCST90693322_1|Body mass index or ovarian cancer (pleiotropy)|MLLT10|10|8.000000e-18","GCST90693322_2|Body mass index or ovarian cancer (pleiotropy)|SKAP1 - Y_RNA|17|1.000000e-08","GCST90693322_3|Body mass index or ovarian cancer (pleiotropy)|C19orf12 - CCNE1|19|1.000000e-09","GCST90693322_4|Body mass index or ovarian cancer (pleiotropy)|DNMT3A|2|1.000000e-09","GCST90693322_5|Body mass index or ovarian cancer (pleiotropy)|TIPARP-AS1|3|1.000000e-09","GCST90693327_1|Waist-to-hip ratio or ovarian cancer (pleiotropy)|PRR5L|11|7.000000e-09","GCST90693327_2|Waist-to-hip ratio or ovarian cancer (pleiotropy)|NAGLU - HSD17B1P1|17|3.000000e-08","GCST90693327_3|Waist-to-hip ratio or ovarian cancer (pleiotropy)|LINC02210-CRHR1|17|2.000000e-20","GCST90693327_4|Waist-to-hip ratio or ovarian cancer (pleiotropy)|TCEA2|20|5.000000e-10","GCST90693327_5|Waist-to-hip ratio or ovarian cancer (pleiotropy)|LINC01828, LINC01829|2|2.000000e-08","GCST90693327_6|Waist-to-hip ratio or ovarian cancer (pleiotropy)|DNMT3A - ARNILA|2|1.000000e-08","GCST90693327_7|Waist-to-hip ratio or ovarian cancer (pleiotropy)|TIPARP-AS1|3|6.000000e-12","GCST90693327_8|Waist-to-hip ratio or ovarian cancer (pleiotropy)|CNTLN|9|3.000000e-08","GCST90693331_1|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|LINC02210-CRHR1|17|4.000000e-20","GCST90693331_2|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|TCEA2|20|4.000000e-11","GCST90693331_3|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|LINC01828, LINC01829|2|3.000000e-09","GCST90693331_4|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|DNMT3A - ARNILA|2|4.000000e-10","GCST90693331_5|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|SYNPO2|4|4.000000e-08","GCST90693331_6|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|CNTLN|9|6.000000e-09","GCST90693331_7|Waist-to-hip ratio adjusted for body mass index or ovarian cancer (pleiotropy)|PRR5L|11|8.000000e-10","GCST90693335_1|Arm fat ratio or ovarian cancer (pleiotropy)|MLLT10|10|5.000000e-11","GCST90693335_2|Arm fat ratio or ovarian cancer (pleiotropy)|NFE2L1 - CBX1|17|1.000000e-10","GCST90693339_1|Trunk fat ratio or ovarian cancer (pleiotropy)|ATAD5|17|7.000000e-11","GCST90693339_2|Trunk fat ratio or ovarian cancer (pleiotropy)|MAPK8IP1P1 - ARL17B|17|2.000000e-13","GCST90693339_3|Trunk fat ratio or ovarian cancer (pleiotropy)|ATP13A2|1|3.000000e-09","GCST90693339_4|Trunk fat ratio or ovarian cancer (pleiotropy)|BNC2 - RN7SL720P|9|7.000000e-16","GCST90693343_1|Leg fat ratio or ovarian cancer (pleiotropy)|ATAD5|17|5.000000e-10","GCST90693343_2|Leg fat ratio or ovarian cancer (pleiotropy)|PNPO|17|4.000000e-08","GCST90693343_3|Leg fat ratio or ovarian cancer (pleiotropy)|BNC2 - RN7SL720P|9|4.000000e-16","GCST90693349_1|Gluteofemoral adipose tissue or ovarian cancer (pleiotropy)|ATAD5|17|2.000000e-08","GCST90693349_2|Gluteofemoral adipose tissue or ovarian cancer (pleiotropy)|KANSL1 - MAPK8IP1P1|17|6.000000e-12","GCST90693352_1|Visceral adipose tissue or ovarian cancer (pleiotropy)|MLLT10|10|2.000000e-10"]}]}